Citi downgraded Kirin (KNBWY) to Neutral from Buy with a price target of 2,800 yen, down from 3,200 yen. The firm cites a reduced value for the company’s pharmaceutical segment following the discontinuation of rocatinlimab for the downgrade.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KNBWY: